Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

OurPet’s Company (OPCO) Honored by Pet Business with 2016 Industry Recognition Award

Before the opening bell, OurPet’s Company (OTCQX: OPCO) announced that it has been awarded a 2016 Industry Recognition Award by the trade publication Pet Business for its innovative OurPets® Switchgrass Natural Cat Litter™ (http://dtn.fm/Ohb71). Originally unveiled at this year’s SuperZoo pet industry convention in Las Vegas, the company’s Switchgrass Natural Cat Litter with Biochar is […]

National Waste Management Holdings, Inc. (NWMH) Protects the Environment with a Range of Green Services

In the ‘Advancing Sustainable Materials Management: 2014 Fact Sheet’ (http://dtn.fm/JH1hf) published last month, the U.S. Environmental Protection Agency (EPA) released statistics on the amount of municipal solid waste (MSW) and construction and demolition (C&D) debris generated by U.S. households and businesses. The rising amounts pose a growing risk to the environment and to our health. […]

Animal Spirits at OurPet’s Company (OPCO) are Propelling Performance

The management at OurPet’s Company (OTCQX: OPCO) is driven by animal spirits. They’ve taken the quite mundane business of pet care and turned it into a high tech, high touch enterprise. Products now range from the groundbreaking OurPets® Big Dog Feeder® (http://dtn.fm/hG4WS) to the Intelligent Pet Care™ line (http://dtn.fm/dK3Al), which uses digital technologies to enhance […]

Cellceutix Corp. (CTIX) Advances Pipeline toward Multi-billion Dollar Opportunities, Piques Peer Interest along the Way

Cellceutix (OTCQB: CTIX) CEO Leo Ehrlich in September issued a fiscal year-end business statement recapping the company’s ability to usher its three unique compounds through various stages of clinical trials to successfully meet primary endpoints and drop anchors in several key markets. Advancements of its current pipeline – spanning dermatology, cancer, infectious disease and gastrointestinal […]

Singlepoint, Inc. (SING) Offers Update on Corporate Initiatives Related to SingleSeed Subsidiary

Before the opening bell, Singlepoint, Inc. (OTC: SING) issued an update on the corporate initiatives being taken by its SingleSeed subsidiary in order to better position itself in the growing domestic cannabis industry. Following November’s vote, more than half of all U.S. states have now legalized marijuana for either recreational or medicinal purposes, leading to […]

Neuralstem, Inc. (CUR) Gets Aegis Update

Neuralstem, Inc. (NASDAQ: CUR) is a biotechnology company whose patented technology allows for the production, on a commercial level, of a number of types of central nervous stem cells. These are in the development stage for the treatment of conditions and diseases of the central nervous system. The company recently announced the start of enrollment […]

Singlepoint (SING) Subsidiary Looks to Help Cannabis Merchants Build Trust, Increase Customer Loyalty

A leading provider of mobile technology and mobile payment solutions serving various markets and industries, Singlepoint, Inc. (OTC: SING) has its eyes set on the fast-growing cannabis industry, aiming to help legal marijuana businesses build trust and increase customer loyalty via subsidiary SingleSeed and its highly reliable payment processing and marketing tools. With eight more […]

European Patent Dispute Spurs Buying Opportunity with Higher Price Target for Alder Biopharmaceuticals (ALDR)

A legal dispute with the European Patent Office over the European patent for its lead product candidate surprisingly presents a strong buying opportunity for clinical stage biopharmaceutical company Alder Biopharmaceuticals, Inc. (NASDAQ: ALDR), according to an analysis report (http://dtn.fm/9UkRd) released by Aegis Capital Corp on November 23. As such, Aegis analysts reiterated a ‘Buy’ rating […]

 

From Our Blog

AI Robotics are Transforming Hotels – And the Shift Has Already Begun

July 14, 2025

AI-driven robotics is no longer the stuff of sci-fi dreams or pilot programs in distant R&D labs. It’s rapidly becoming the backbone of day-to-day operations in sectors that were once considered too human-centric for automation. Nowhere is this more apparent than in hospitality, where persistent labor shortages, rising wage pressures, and demanding guest expectations are […]

Rotate your device 90° to view site.